跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUNITINIB EGIS 50 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUNITINIB EGIS 50 MG CAPSULAS DURAS EFG
Approved
STANDARD
SUNITINIB EGIS 50 MG CAPSULAS DURAS EFG
Egis Pharmaceuticals Plc.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 17, 2021
Approval ID
b227e7845b73d43e
Company
Egis Pharmaceuticals Plc.
Type
Standard
Approval Details
Approval Id
b227e7845b73d43e
Drug Cima Aemps Name
SUNITINIB EGIS 50 MG CAPSULAS DURAS EFG
Register Number
86032
Holder Company Name
Egis Pharmaceuticals Plc.
Marketing Company Name
Egis Pharmaceuticals Plc.
Authorization Date
2021-06-17
Dosage Form
CÁPSULA DURA
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Egis Pharmaceuticals Plc.
Active Ingredients
SUNITINIB CICLAMATO
72,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 17, 2021
Approval ID
b227e7845b73d43e
Type
Standard
Back to CIMA-AEMPS Approvals